CVE-2024-43411

CKEditor4 has a low risk cross-site scripting (XSS) vulnerability from domain takeover

Description

CKEditor4 is an open source what-you-see-is-what-you-get HTML editor. A theoretical vulnerability has been identified in CKEditor 4.22 (and above). In a highly unlikely scenario where an attacker gains control over the https://cke4.ckeditor.com domain, they could potentially execute an attack on CKEditor 4 instances. The issue impacts only editor instances with enabled version notifications. Please note that this feature is disabled by default in all CKEditor 4 LTS versions. Therefore, if you use CKEditor 4 LTS, it is highly unlikely that you are affected by this vulnerability. If you are unsure, please contact us. The fix is available in version 4.25.0-lts.

Category

3.1
CVSS
Severity: Low
CVSS 3.1 •
EPSS 0.07%
Affected: ckeditor ckeditor4
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2024-43411?
CVE-2024-43411 has been scored as a low severity vulnerability.
How to fix CVE-2024-43411?
To fix CVE-2024-43411, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2024-43411 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2024-43411 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2024-43411?
CVE-2024-43411 affects ckeditor ckeditor4.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.